Cipla Limited, a global pharmaceutical company, has launched an artificial intelligence-powered initiative called ...

A recent bronchoscopy, lung infection, and course of antibiotics left columnist Sam Kirton feeling exhausted and frustrated.

Inhaled corticosteroids use is common in bronchiectasis, even among patients who don’t meet guideline criteria for ICS use.

The replicate confirmatory KALOS and LOGOS trials evaluated BGF in participants with severe asthma inadequately controlled with standard of care.

AstraZeneca has taken a key step in advancing Breztri Aerosphere toward a potential label expansion and achieving its goal of ...

AstraZeneca said on Friday its triple-combination inhaler Breztri Aerosphere met all main goals in two late-stage trials for ...

Inhibikase (IKT) pivots to IkT-001Pro for PAH amid competition like Merck’s sotatercept. Backed by $97.5M, results will ...

With mepolizumab vs. placebo, patients with COPD and type 2 inflammation experienced significantly fewer moderate/severe ...

Verona Pharma’s Ohtuvayre generated $71.3M in Q1'25 sales, signaling blockbuster potential. Read more on VRNA’s upcoming ...

Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic ...

Last year, the FDA approved the biologic drug Dupixent to treat uncontrolled eosinophilic COPD. The approval marked a step ...